IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of American Renal Associates Holdings, Inc. and Advises Investors With Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)-- Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE: ARA) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at [email protected].

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The investigation focuses on whether the Company and certain of its officers and/or directors have engaged in Health Insurance Fraud and breached their fiduciary duties. According to some reports, American Renal has been luring patients away from affordable Medicare and Medicaid programs and convincing them to sign up with UnitedHealthcare of Florida, Inc., UnitedHealthcare of Ohio, Inc. and All Savers Insurance Company for dialysis services rendered to patients suffering from end-stage renal disease, in order to boost its own profits when billing.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160826005842/en/

Lundin Law PC
Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

[email protected]

http://lundinlawpc.com/

Source: Lundin Law PC